BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3287278)

  • 1. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
    Rovinski B; Benchimol S
    Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
    Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
    Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
    Tuck SP; Crawford L
    Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
    Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
    Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
    Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
    Conzen SD; Cole CN
    Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras].
    Pospelova TV; Kisliakova TV; Medvedev AV; Svetlikova SB; Pospelov VA
    Tsitologiia; 1990; 32(2):148-55. PubMed ID: 2142348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Model systems of carcinogenesis in vitro: the interaction of the ras oncogene with immortalized cells].
    Topol' LZ; SpitkovskiÄ­ DD; Kiselev FL
    Biull Eksp Biol Med; 1988 Mar; 105(3):329-32. PubMed ID: 3280050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
    Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective role of p53 in Ras-induced transformation of REF52 cells].
    Kopnin PB; Ivanov AV; Il'inskaia GV; Sablina AA; Kopnin BP; Chumakov PM
    Mol Biol (Mosk); 2003; 37(3):458-71. PubMed ID: 12815953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
    Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
    Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation of human cells in vitro.
    Rhim JS
    Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
    Schmid G; Kramer MP; Wesierska-Gadek J
    J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.